A Pilot Phase IIB, Randomized, Multi-Center Trial of Agratroban in Combination with Recombinant Tissue Plasminogen Activator for Acute Stroke (ARTSS-2)

Grant

Date/time Interval

  • March 1, 2013 - February 28, 2014
  • Total Award Amount

  • 31794.00
  • Direct Costs

  • 21702.00
  • Sponsor Award Id

  • Contributor

  • Michael Lyerly   Investigator